A dual role of Erk signaling in embryonic stem cells

Slides:



Advertisements
Similar presentations
Myc Represses Primitive Endoderm Differentiation in Pluripotent Stem Cells Keriayn N. Smith, Amar M. Singh, Stephen Dalton Cell Stem Cell Volume 7, Issue.
Advertisements

Oxidative stress and hypoxia in normal and leukemic stem cells Ugo Testa, Catherine Labbaye, Germana Castelli, Elvira Pelosi Experimental Hematology Volume.
GSK3β inhibition activates the CDX/HOX pathway and promotes hemogenic endothelial progenitor differentiation from human pluripotent stem cells Kenji Kitajima,
Fabian Mohr, Konstanze Döhner, Christian Buske, Vijay P.S. Rawat 
Susanne Wingert, Michael A. Rieger  Experimental Hematology 
Cancer: Inappropriate Expression of Stem Cell Programs?
FoxO: A New Addition to the ESC Cartel
Ling Guo, Robert C.H. Zhao, Yaojiong Wu  Experimental Hematology 
Nishitha M. Reddy, Olalekan Oluwole, John P. Greer, Brian G
Cassie J. Clarke, Tessa L. Holyoake  Experimental Hematology 
162. Stability of Polymer/Plasmid DNA Complexes In Vitro and In Vivo
281. Rapid Generation of Induced Pluripotent Stem Cells (iPSCs) from the Urine of a Patient with Duchenne Muscular Dystrophy    Molecular Therapy  Volume.
Christa Buecker, Niels Geijsen  Cell Stem Cell 
Screening for Novel Regulators of Embryonic Stem Cell Identity
Natalia J. Martinez, Richard I. Gregory  Cell Stem Cell 
Velizar Shivarov, Lars Bullinger  Experimental Hematology 
Wing Y. Chang, William L. Stanford  Cell Stem Cell 
Screening for Novel Regulators of Embryonic Stem Cell Identity
Induced pluripotent stem cell technology: A window for studying the pathogenesis of acquired aplastic anemia and possible applications  Mahmoud I. Elbadry,
Ya-Huei Kuo, Jing Qi, Guerry J. Cook  Experimental Hematology 
Kaitlin A. Read, Michael D. Powell, Paul W. McDonald, Kenneth J
343. Benchtop DNA Synthesizer: Oligo-Templated Polymerization (OTP)
MicroRNA Regulation of Stem Cell Fate
Short Telomeres Flirt with Stem Cell Commitment
Plasticity of Adult Stem Cells
CBP/Catenin antagonists: Targeting LSCs’ Achilles heel
Volume 11, Issue 1, Pages 1-3 (July 2018)
Getting blood from bone: An emerging understanding of the role that osteoblasts play in regulating hematopoietic stem cells within their niche  Yusuke.
The Nexus of Tet1 and the Pluripotency Network
Quiescence regulators for hematopoietic stem cell
Qiuping He, Suwei Gao, Junhua Lv, Wei Li, Feng Liu 
Oceans of opportunity: Exploring vertebrate hematopoiesis in zebrafish
Induced pluripotent stem cell modeling of malignant hematopoiesis
Xiaoou Zhou, Malcolm K. Brenner  Experimental Hematology 
Mira Jeong, Margaret A. Goodell  Experimental Hematology 
Christopher E. Schmitt, Carlos O. Lizama, Ann C. Zovein 
Arterial identity of hemogenic endothelium: a key to unlock definitive hematopoietic commitment in human pluripotent stem cell cultures  Igor I. Slukvin,
Stress Flips a Chromatin Switch to Wake Up Latent Virus
Giulia Caglio, Elena Torlai Triglia, Ana Pombo  Cell Stem Cell 
Susanne Wingert, Michael A. Rieger  Experimental Hematology 
Peter Karagiannis, Shinya Yamanaka, Megumu K. Saito 
Clonal heterogeneity as a driver of disease variability in the evolution of myeloproliferative neoplasms  Janine Prick, Gerald de Haan, Anthony R. Green,
660. Bowel/Bladder Sensation and Control in Patients with Spinal Cord Injury Treated with Human Embryonic Stem Cell Therapy  Geeta Shroff  Molecular Therapy 
Volume 132, Issue 6, Pages (March 2008)
Impact of HDAC inhibitors on dendritic cell functions
Determination of complex subclonal structures of hematological malignancies by multiplexed genotyping of blood progenitor colonies  Francesca L. Nice,
Nanog Cell Volume 113, Issue 5, Pages (May 2003)
Mitotic Bookmarking: Maintaining the Stem Cell Identity during Mitosis
Optimizing autologous cell grafts to improve stem cell gene therapy
Inside This Issue Experimental Hematology
Sietske T. Bakker, Emmanuelle Passegué  Experimental Hematology 
Fabian Mohr, Konstanze Döhner, Christian Buske, Vijay P.S. Rawat 
Pluripotency without Proliferation
Tumor necrosis factor α in the onset and progression of leukemia
Polycomb Repression under the Skin
Pharmacological activation of wild-type p53 in the therapy of leukemia
Volume 56, Issue 4, Pages (October 1999)
TGFβ and SMADs Talk to NANOG in Human Embryonic Stem Cells
Capturing Totipotent Stem Cells
Kinase signaling and targeted therapy for primary myelofibrosis
Regulatory Principles of Pluripotency: From the Ground State Up
Ashley A. Newcombe, Brenda E.S. Gibson, Karen Keeshan 
740. Prevention of Radiation-Induced Lung Injury by Administration of Gene-Modified Mesenchymal Stem Cells    Molecular Therapy  Volume 20, Pages S285-S286.
Stem cell biology and the plasticity polemic
Kazim H Narsinh, Jordan Plews, Joseph C Wu  Molecular Therapy 
Capturing Pluripotency
Matthew I. Stein, Jiang Zhu, Stephen G. Emerson 
Ye-Guang Chen, Zhongwei Li, Xiao-Fan Wang  Cell Stem Cell 
Pediatric leukemia: Moving toward more accurate models
Moving Toward the Ground State
Presentation transcript:

A dual role of Erk signaling in embryonic stem cells Xinwei Ma, Haixia Chen, Lingyi Chen  Experimental Hematology  Volume 44, Issue 3, Pages 151-156 (March 2016) DOI: 10.1016/j.exphem.2015.12.008 Copyright © 2016 ISEH - International Society for Experimental Hematology Terms and Conditions

Figure 1 Schematic illustration of Erk signaling in ESCs. Conventional Ras/Mek/Erk signaling activates the expression of Elk1, c-Fos, p53, c-Jun, and so on, consequently promoting cell proliferation, cell cycle progression, and telomere maintenance. Erk signaling also suppresses the expression of pluripotency genes, such as Nanog, Krdm14, Tbx3, and Klf4. In additional to Erk, Mek may fulfill its function through an unidentified factor to repress pluripotency genes, including Nanog, Tbx3, and Klf4. Experimental Hematology 2016 44, 151-156DOI: (10.1016/j.exphem.2015.12.008) Copyright © 2016 ISEH - International Society for Experimental Hematology Terms and Conditions

Figure 2 Dual role of Erk signaling in mouse ESCs. A minimal level of Erk signaling (marked by a green dashed line) is required for cell proliferation, cell cycle progression, suppression of apoptosis, telomere length maintenance, and genomic stability. Above a certain threshold (represented by a red dashed line), Erk signaling represses the expression of pluripotency genes and activates the expression of developmental genes. Thus, an intermediate Erk signaling strength is optimal for pluripotency maintenance. Experimental Hematology 2016 44, 151-156DOI: (10.1016/j.exphem.2015.12.008) Copyright © 2016 ISEH - International Society for Experimental Hematology Terms and Conditions